TGFB1 and hepatocellular carcinoma: Other modulators in the TME, such as Tregs, release the cytokines IL-8, IL-10, and TGF-β to downregulate NKG2D ligand membrane expression in HSCs, which suggests tumor progression in HCC patients (72).